Job Description
Posted 24 September 2024 Salary Up to €70000 per annum + Remote Working Location Dublin Job type Permanent Discipline Life Sciences & Engineering Technologies , Science Leaders & Specialists Reference BBBH30482_ Contact Treasa Prior
Our client is an innovative pharmaceutical and biotech organisation focused on health and nutrition, developing and marketing products that address and support nutritional deficiencies in patients.
They now require a CMC Technical Writer , to join their growing team based out of Dublin, working remotely from the beginning with the flexibility to travel to and from their operations in Milan when required. This is a really exciting role that offers a unique opportunity for someone who is eager to contribute to the early stages of bringing an innovative drug product to market, playing a key part in shaping its success and regulatory approval.
The Position
- Write and review technical documents (development reports, protocols, study reports).
- Author and compile regulatory documents (CMC sections).
- Assist in developing and updating regulatory filings, including master files, technical files for medical devices, and CTDs for drug approvals.
- Establish and maintain a document management system.
- Collaborate with cross-functional, international teams for input and feedback.
The Person
- PhD or Master's in science (Chemical Engineering, Chemistry, Bio-Chemistry, Pharmacy, or related field).
- 3+ years of experience in GMP manufacturing or CMC writing.
- Knowledge of CMC processes, including drug substance/product manufacturing, stability, analytical and formulation development.
- Ability to convert technical information into regulatory-compliant documentation.
- Strong communication, planning, and organizational skills.
- Able to manage multiple tasks independently in a fast-paced environment.
The Benefits
- Significant career growth and opportunities.
To learn more about this opportunity, apply online or contact Treasa Prior at HRM Search Partners at , for a confidential discussion.
#J-18808-Ljbffr